{"id":2562,"date":"2010-12-24T10:15:37","date_gmt":"2010-12-24T15:15:37","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=2562"},"modified":"2010-12-24T10:15:37","modified_gmt":"2010-12-24T15:15:37","slug":"survey-type-2-diabetes-patients-would-switch-from-insulin","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=2562","title":{"rendered":"Survey: Type-2 Diabetes Patients Would Switch from Insulin"},"content":{"rendered":"<figure id=\"attachment_1304\" aria-describedby=\"caption-attachment-1304\" style=\"width: 300px\" class=\"wp-caption alignright\"><a href=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Calculator.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1304\" title=\"Calculator\" src=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Calculator.jpg\" alt=\"Calculator keys (Investor.gov)\" width=\"300\" height=\"200\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Calculator.jpg 300w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/Calculator-150x100.jpg 150w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><figcaption id=\"caption-attachment-1304\" class=\"wp-caption-text\">(Investor.gov)<\/figcaption><\/figure>\n<p>A new survey shows 60 percent of type-2 diabetes patients in the U.S. who currently use insulin say they would prefer switching to a less expensive bio-similar insulin if such an agent became available.\u00a0 <a href=\"http:\/\/decisionresources.com\/News-and-Events\/Press-Releases\/Patient-Forum-in-Type-2-Diabetes-122310\">Decision Resources<\/a>, a health care industry research firm, conducted the survey of diabetes patients in September 2010.<\/p>\n<p>Decision Resources reports most surveyed type-2 diabetes patients indicate that they have some form of prescription coverage associated with their insurance, but patients taking insulin still say that they feel their disease is a greater financial burden compared to other types of patients.<\/p>\n<p>The majority of insulin users surveyed say they are also taking at least one oral anti-diabetic, resulting in multiple co-payments each month, increasing the monthly out-of-pocket cost for these patients. The cost of test strips and glucose meters to check blood glucose levels twice a day adds another cost to patients.<\/p>\n<p>The report, <em>Patient Forum in Type-2 Diabetes: Patients Resistance to Injectable Agents May Cause Challenges for Emerging GLP-1 Analogues<\/em>, is based on a survey of 502 U.S. diabetes patients. To take part in the survey, patients must have been between 18 and 80 years old, been diagnosed with type-2 diabetes by a physician, and been taking prescription medication for their diabetes at the time.<\/p>\n<p>Related:\u00a0 <a href=\"http:\/\/sciencebusiness.technewslit.com\/?p=2382\">Disposable Insulin Device Gets FDA Clearance<\/a><\/p>\n<p style=\"text-align: center;\">*\u00a0\u00a0\u00a0\u00a0 *\u00a0\u00a0\u00a0\u00a0 *<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new survey shows 60 percent of type-2 diabetes patients in the U.S. who currently use insulin say they would prefer switching to a less expensive bio-similar insulin if such an agent became available.\u00a0 Decision Resources, a health care industry research firm, conducted the survey of diabetes patients in September 2010. Decision Resources reports most [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[53,27,129],"class_list":["post-2562","post","type-post","status-publish","format-standard","hentry","category-business","tag-economics","tag-pharmaceuticals","tag-statistics"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/2562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2562"}],"version-history":[{"count":3,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/2562\/revisions"}],"predecessor-version":[{"id":2565,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/2562\/revisions\/2565"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}